Prosecution Insights
Last updated: May 29, 2026
Application No. 18/647,000

POLYCARBONATE COMPOSITIONS

Final Rejection §103
Filed
Apr 26, 2024
Priority
Nov 14, 2017 — provisional 62/585,826 +2 more
Examiner
USELDING, JOHN E
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
BASF Corporation
OA Round
4 (Final)
53%
Grant Probability
Moderate
5-6
OA Rounds
7m
Est. Remaining
71%
With Interview

Examiner Intelligence

Grants 53% of resolved cases
53%
Career Allowance Rate
678 granted / 1272 resolved
-11.7% vs TC avg
Strong +18% interview lift
Without
With
+17.9%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
50 currently pending
Career history
1337
Total Applications
across all art units

Statute-Specific Performance

§101
0.3%
-39.7% vs TC avg
§103
67.2%
+27.2% vs TC avg
§102
4.7%
-35.3% vs TC avg
§112
3.4%
-36.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1272 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claim(s) 20 and 23 is/are rejected under 35 U.S.C. 103 as being unpatentable over Schrinner et al. (2003/0109611) in view of Eiffler et al. (5,362,783). Regarding claim 20: Shrinner et al. teach an additive composition comprising diphenyl isodecyl phosphite (DPDP) and the following benzofuranone stabilizer: PNG media_image1.png 322 276 media_image1.png Greyscale [Example 1; Table 1]. Shrinner et al. also teach an additive composition comprising the organic phosphite stabilizer Irgafos 168 and the following benzofuranone stabilizer: PNG media_image1.png 322 276 media_image1.png Greyscale [Example 2; Table 2]. Shrinner et al. also teach Irgastab PUR 68, which is a commercially available additive composition that comprises the claimed benzofuranone stabilizer and a phosphite stabilizer [0118]. Shrinner et al. fail to teach an organic phosphine. However, Eiffler et al. teach adding an organic phosphine to an additive stabilizer composition comprising an organic phosphite, such as Irgaphos 168, to stabilize thermoplastic polymers against discoloration (column 1, lines 5-11, column 2, lines 5-15; column 6, lines 37-63). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to add an organic phosphine as taught by Eiffler et al. to the additive composition of Shrinner et al. to stabilize against discoloration. Regarding claim 23: Schrinner et al. teach adding UV absorbers [0094-0102]. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to add a UV absorber to the composition of Schrinner et al. to stabilize the composition. Response to Arguments Applicant's arguments filed 2/3/2026 have been fully considered but they are not persuasive. The Applicant alleges that Eiffler teaches away from the combination of a phosphine with a phosphonite. This is not persuasive because the section cited by the Applicant is referring to the combination of a phosphine with the particular diphosphonate Irgahphos-PEPQ. However, Eiffler specifically teaches that a phosphine can be combine with the phosphite Irgaphos 168 (column 16, lines 55-64). The diphosphonate Irgaphos-PEPQ is a very different structure than the phosphite Irgaphos 168. It is noted that there is not a diphosphonate in the examples of Schrinner et al. The Applicant has alleged that Eiffler teaches that a phosphine and a hindered phenol provide better results, and that the skilled artisan could not derive any reasonable expectation of success of adding an organic phosphine. This is not persuasive because Eiffler specifically teaches that a phosphine can be combine with the phosphite Irgaphos 168 (column 16, lines 55-64). The Applicant has made the argument that Eiffler does not suggest that compound A could be used to improve yellowing. In response to applicant's arguments against the references individually, one cannot show nonobviousness by attacking references individually where the rejections are based on combinations of references. See In re Keller, 642 F.2d 413, 208 USPQ 871 (CCPA 1981); In re Merck & Co., 800 F.2d 1091, 231 USPQ 375 (Fed. Cir. 1986). The reason or motivation to modify the reference may often suggest what the inventor has done, but for a different purpose or to solve a different problem. It is not necessary that the prior art suggest the combination to achieve the same advantage or result discovered by applicant. See, e.g., In re Kahn, 441 F.3d 977, 987, 78 USPQ2d 1329, 1336 (Fed. Cir. 2006) (motivation question arises in the context of the general problem confronting the inventor rather than the specific problem solved by the invention); Cross Med. Prods., Inc. v. Medtronic Sofamor Danek, Inc., 424 F.3d 1293, 1323, 76 USPQ2d 1662, 1685 (Fed. Cir. 2005) ("One of ordinary skill in the art need not see the identical problem addressed in a prior art reference to be motivated to apply its teachings."); In re Linter, 458 F.2d 1013, 173 USPQ 560 (CCPA 1972) (discussed below); In re Dillon, 919 F.2d 688, 16 USPQ2d 1897 (Fed. Cir. 1990), cert. denied, 500 U.S. 904 (1991). See MPEP 2144. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOHN USELDING whose telephone number is (571)270-5463. The examiner can normally be reached on M-F 8am to 6:30pm. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached on 571-272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOHN E USELDING/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Show 1 earlier event
Jan 31, 2025
Non-Final Rejection mailed — §103
Apr 30, 2025
Response Filed
May 19, 2025
Final Rejection mailed — §103
Sep 19, 2025
Request for Continued Examination
Sep 22, 2025
Response after Non-Final Action
Oct 06, 2025
Non-Final Rejection mailed — §103
Feb 03, 2026
Response Filed
Feb 27, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12637540
RESIN PRODUCED BY POLYCONDENSATION, AND RESIN COMPOSITION
4y 0m to grant Granted May 26, 2026
Patent 12606484
MICROFIBROUS SHOTCRETE MIXTURE
3y 1m to grant Granted Apr 21, 2026
Patent 12600669
SELF-HEALING POLYMER-MODIFIED CEMENTS FOR AMBIENT TEMPERATURE APPLICATIONS
3y 6m to grant Granted Apr 14, 2026
Patent 12600856
RESIN COMPOSITION, FORMED ARTICLE, AND, FORMED ARTICLE WITH HARD COAT LAYER
3y 2m to grant Granted Apr 14, 2026
Patent 12600809
ETHYLENE-VINYL ALCOHOL COPOLYMER COMPOSITION, AND PREPARATION METHOD THEREFOR
3y 0m to grant Granted Apr 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
53%
Grant Probability
71%
With Interview (+17.9%)
2y 8m (~7m remaining)
Median Time to Grant
High
PTA Risk
Based on 1272 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month